Seeyond’s Quest Diagnostics DGX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q4
$5.17M Buy
33,065
+1,326
+4% +$191K 0.5% 39
2022
Q3
$3.89M Buy
31,739
+11,089
+54% +$1.46M 0.47% 40
2022
Q2
$2.75M Sell
20,650
-4,246
-17% -$579K 0.31% 75
2022
Q1
$3.41M Buy
24,896
+6,946
+39% +$968K 0.34% 60
2021
Q4
$3.1M Sell
17,950
-4,915
-21% -$748K 0.29% 79
2021
Q3
$3.32M Buy
22,865
+680
+3% +$99.5K 0.32% 60
2021
Q2
$2.93M Buy
22,185
+165
+0.7% +$21.6K 0.27% 80
2021
Q1
$2.83M Buy
22,020
+3,795
+21% +$468K 0.28% 73
2020
Q4
$2.17M Sell
18,225
-1,255
-6% -$153K 0.22% 134
2020
Q3
$2.23M Buy
19,480
+5,445
+39% +$643K 0.24% 104
2020
Q2
$1.6M Sell
14,035
-1,348
-9% -$143K 0.18% 163
2020
Q1
$242K Buy
15,383
+2,708
+21% +$280K 0.03% 478
2019
Q4
$1.35M Buy
12,675
+649
+5% +$67.7K 0.14% 255
2019
Q3
$1.29M Buy
12,026
+996
+9% +$102K 0.13% 268
2019
Q2
$1.12M Sell
11,030
-4,428
-29% -$426K 0.12% 284
2019
Q1
$1.39M Buy
15,458
+3,077
+25% +$267K 0.13% 252
2018
Q4
$1.03M Buy
+12,381
New +$1.16M 0.14% 229

Other funds holding DGX

Seeyond's DGX Position: Q4 2022 in Review

Seeyond increased its Quest Diagnostics (DGX) stake by 4.2% in Q4 2022, buying an estimated $191K and bringing the position to 33,065 shares worth $5.17M. The position accounts for 0.5% of the portfolio, ranked #39.

Seeyond first reported a position in DGX in Q4 2018 and has held it in 17 quarters since. 879 funds tracked by Wall St. Rank hold DGX as of Q4 2022.

  • Seeyond held 33,065 shares of Quest Diagnostics worth $5.17M as of Q4 2022.
  • Seeyond bought 1,326 Quest Diagnostics shares in Q4 2022, an estimated $191K.
  • Quest Diagnostics made up 0.5% of Seeyond's portfolio in Q4 2022, its #39 holding.
  • Seeyond first reported a position in Quest Diagnostics in Q4 2018 and has held it in 17 quarters since.
  • 879 funds tracked by Wall St. Rank held Quest Diagnostics as of Q4 2022.

Based on Seeyond's 13F filing for Q4 2022, filed 13 Feb 2023.